CN101254241A - 消疣康复合剂 - Google Patents
消疣康复合剂 Download PDFInfo
- Publication number
- CN101254241A CN101254241A CNA2008100149576A CN200810014957A CN101254241A CN 101254241 A CN101254241 A CN 101254241A CN A2008100149576 A CNA2008100149576 A CN A2008100149576A CN 200810014957 A CN200810014957 A CN 200810014957A CN 101254241 A CN101254241 A CN 101254241A
- Authority
- CN
- China
- Prior art keywords
- root
- radix
- raw materials
- concha
- ruddle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000000260 Warts Diseases 0.000 title claims abstract description 27
- 201000010153 skin papilloma Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 230000035876 healing Effects 0.000 title claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000007670 refining Methods 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 239000010231 banlangen Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 13
- 241000934136 Verruca Species 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 3
- 235000005881 Calendula officinalis Nutrition 0.000 abstract 3
- 240000001432 Calendula officinalis Species 0.000 abstract 3
- 241000334160 Isatis Species 0.000 abstract 3
- 241000237502 Ostreidae Species 0.000 abstract 3
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 3
- 241001106477 Paeoniaceae Species 0.000 abstract 3
- 235000020636 oyster Nutrition 0.000 abstract 3
- 241001061264 Astragalus Species 0.000 abstract 2
- 241000843353 Embelia Species 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 2
- 210000004233 talus Anatomy 0.000 abstract 2
- 241000605372 Fritillaria Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007368 endocrine function Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 206010000496 acne Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010004173 Basophilia Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 208000005775 Parakeratosis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000021145 human papilloma virus infection Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及药物配方领域,具体地说是一种消疣康复合剂。采用紫贝齿、牡蛎、代赭石、磁石、赤芍、金银花、板兰根、蚤休、黄芪为原料制备而成,将紫贝齿、牡蛎、代赭石、磁石、赤芍、金银花、板兰根、蚤休、黄芪洗净后,用水浸泡,然后煎熬,去渣得滤液,灭菌,经提炼后制得合剂,其特征是原料组成以重量百分比计为:为紫贝齿16-22%,牡蛎8-11%、代赭石10-16%、磁石10-16%、赤芍8-11%、金银花8-11%、板兰根10-16%、蚤休7-10%、黄芪3-7%,各原料组分百分比之和等于百分之百。本发明原料成本低,加工工艺简单,无毒副作用,接受性强,临床易于推广,治疗扁平疣效果好。
Description
技术领域
本发明涉及一种中成药制剂,具体地说是一种用于治疗扁平疣的消疣康复合剂。
背景技术
我们知道,扁平疣是一种人乳头瘤病毒感染引起的皮肤病,在致病的过程中,机体的免疫系统功能低下,外周血T细胞亚群异常,免疫监视作用尤其是自然杀伤细胞的活性减低引发本病,另外,扁平疣好发于内分泌功能旺盛的青少年,故亦与内分泌功能失调有关。由于此病好发于青年人的面部、手背、上肢等部位,又称青年扁平疣,不经治疗,局部扁平丘疹会逐渐增多,颜色加深,严重影响美观,故要求治疗的患者越来越多。目前我国对此病的治疗,对于疣体数目少的患者,以激光、电灼、冷冻等局部治疗,但有一定的创伤性、不安全性、留有疤痕及增加感染机率;对疣体数目多的患者,有采用胸腺肽注射液、利巴韦林、聚肌胞等药物治疗,治疗时间长,疗效普遍不理想,且易复发。近年来中药用于治疗扁平疣日益显示出了它的优势。
发明内容
本发明所需要解决的技术问题是为了克服上述现有技术的不足,提供一种无毒副作用的治疗扁平疣中药制剂。
本发明解决上述技术问题采用的技术方案是:一种消疣康复合剂,采用紫贝齿、牡蛎、代赭石、磁石、赤芍、金银花、板兰根、蚤休、黄芪为原料制备而成,将紫贝齿、牡蛎、代赭石、磁石、赤芍、金银花、板兰根、蚤休、黄芪洗净后,用水浸泡,然后煎熬,去渣得滤液,灭菌,经提炼后制得合剂,其特征是原料组成以重量百分比计为:为紫贝齿16-22%,牡蛎8-11%、代赭石10-16%、磁石10-16%、赤芍8-11%、金银花8-11%、板兰根10-16%、蚤休7-10%、黄芪3-7%,各原料组分百分比之和等于百分之百。
本发明的有益效果是:原料成本低,加工工艺简单,无毒副作用,接受性强,临床易于推广,治疗扁平疣效果好。
具体实施方式
下面结合实施例对本发明作进一步的描述:
实施例1:
本实施例消疣康复合剂采用紫贝齿、牡蛎、代赭石、磁石、赤芍、双花、板兰根、蚤休、黄芪为原料制备而成。其组分(重量%)为紫贝齿22、牡蛎11、代赭石10、磁石15、赤芍8、金银花8、板兰根16、蚤休7、黄芪3。取上述九种原料总重量58千克,精选洗净后,先将药物用水浸泡30分钟然后煎熬。头煎加水12000ml,以没过药面一寸为宜,先用武火,煎沸后改为文火,煎熬35分钟取汁4500ml;二煎加水8000ml,用武火煎沸后改为文火,煎熬25分钟取汁4500ml。两煎混合,经常规去渣过滤、高压、灭菌工艺后,所得滤液共9000ml,分袋真空包装,每袋150ml。避光、常温保存。
本发明治疗原则:扁平疣属于中医学扁瘊范畴,临床治疗仍依据中医整体观念和辨证施治理论为指导。其一病位在皮肤,当从肺论治,以宣通肺气,行气活血,化瘀生新,祛风清热,散结消疣;其二,此病与肝的关系颇为密切,常由感受风热湿毒,内动肝火所致,也可由肝气郁结,脾气不运,气血湿凝滞,发于肌肤而成。薛己在《外科枢要》中指出:“疣属肝胆少阳经,风热血燥,或怒动肝火,或肝客淫气所致。”以疏肝理气,清解郁火邪毒,祛瘀化疣。故肝郁脾肺气虚,热毒瘀血阻络是其病理基础,以清热解毒,活血化瘀,软坚散结,扶正消疣为治疗原则。本发明组分中紫贝齿性味咸平,归肝经,本品具介类潜阳作用,又兼安神,故具有清肝泻火、理气解郁,安神之功。牡蛎性味咸微寒,归肝肾经,本品能软坚以散结块,平肝潜阳之功,二者为主药,能有效改善机体免疫系统、内分泌功能,提高机体抗病毒能力。代赭石性味苦寒,归肝心经,本品苦寒,质重性坠,具平肝阳、清肝火、降逆之功。磁石性味辛咸寒,质重沉降,归心肝肾三经,具有平肝潜阳、益肝阴、安神之功。赤芍性味苦微寒,本品能清血分郁热,祛瘀行滞,泻肝火,故有清热凉血、祛瘀、活血之功。三药能促进机体代谢,调整机体内分泌功能,并有抗炎、镇静作用。金银花性味甘寒,归肺经,本品能清热解毒,且有轻宣疏散之效,为皮肤科常用的清热解毒药。板兰根性味苦寒,本品具有较强的清热解毒、凉血消斑功能,常用于治疗热毒壅于血分证。蚤休具有清热解毒和消肿止痛、清肝热息风之功。此三药清热解毒,现代药理研究均具有抗病毒作用,近年临床主要用于病毒感染性疾病。黄芪性味甘微温,归脾肺经,本品固护肺气、又益卫气,又能健脾补气,现代药理研究,具有提高机体免疫功能。诸药合用,本发明的组方,可整体有效地改善免疫系统、内分泌系统的功能,提高防病能力和抗病毒、抗炎作用,适用于各种扁平疣的治疗,疗效确切。
本发明各原料还可按下表所列比例(重量百分比)混合的实施例来实现。其加工工艺与实施例1相同。
实施例 | 紫贝齿 | 牡蛎 | 代赭石 | 磁石 | 赤芍 | 金银花 | 板兰根 | 蚤休 | 黄芪 |
实施例2 | 16 | 8 | 16 | 16 | 11 | 9 | 10 | 7 | 7 |
实施例3 | 20 | 9 | 11 | 12 | 9 | 11 | 12 | 10 | 6 |
实施例4 | 18 | 10 | 15 | 10 | 10 | 10 | 15 | 9 | 3 |
实施例5 | 21 | 8 | 10 | 13 | 9 | 9 | 16 | 8 | 6 |
下面结合我院,即山东省威海市文登中心医院进行的临床试验对本发明作进一步、详细地描述:
1、病例选择:临床随机选择52例患者,其中男17例,女35例,年龄12-43岁,中位年龄24岁。病程2-34个月,中位病程15个月。疣体位于面部31例,手背部24例,上肢1例,其中,疣体位于面部及手背部3例,位于手背部及左上肢1例。
2、诊断标准:参照1995年《中华人民共和国中医药行业标准》制定,皮损处呈米粒至高粱粒大小扁平丘疹,表面光滑,孤立散在,淡黄褐色、淡红色、暗红色或正常皮肤色,或微痒;多发于暴露部位,颜面、手背等;有自家接种的特点,可见同形反应;好发于青少年。组织病理检查示表皮棘层肥厚,乳头瘤样增生和角化过度,伴角化不全,棘层上部和颗粒层有空泡化细胞,核深染,嗜碱性。
3、治疗方法:每次服用消疣复康合剂150mL,每日早、晚两次温服,半个月为一个疗程,连续服用本发明两个疗程。
4、疗效标准:治愈:皮疹消退,无新出皮疹;好转:皮疹较前变平,消退30%以上,或有个别新疹出现;未愈:皮疹无变化或消退不足30%。
5、治疗结果:本发明治疗52例,服药两个疗程,结果治愈24例,显效26例,无效2例,治愈率46%,有效率50%,无效率4%,总有效率为96%。
Claims (1)
1、一种消疣康复合剂,采用紫贝齿、牡蛎、代赭石、磁石、赤芍、金银花、板兰根、蚤休、黄芪为原料制备而成,将紫贝齿、牡蛎、代赭石、磁石、赤芍、金银花、板兰根、蚤休、黄芪洗净后,用水浸泡,然后煎熬,去渣得滤液,灭菌,经提炼后制得合剂,其特征是,原料组成以重量百分比计为:为紫贝齿16-22%,牡蛎8-11%、代赭石10-16%、磁石10-16%、赤芍8-11%、金银花8-11%、板兰根10-16%、蚤休7-10%、黄芪3-7%,各原料组分百分比之和等于百分之百。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100149576A CN101254241B (zh) | 2008-04-03 | 2008-04-03 | 一种用于治疗扁平疣的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100149576A CN101254241B (zh) | 2008-04-03 | 2008-04-03 | 一种用于治疗扁平疣的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101254241A true CN101254241A (zh) | 2008-09-03 |
CN101254241B CN101254241B (zh) | 2012-02-01 |
Family
ID=39889564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100149576A Expired - Fee Related CN101254241B (zh) | 2008-04-03 | 2008-04-03 | 一种用于治疗扁平疣的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101254241B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010086660A1 (en) * | 2009-01-30 | 2010-08-05 | Aria Healthcare Limited | Apparatus, method and composition for topical treatment of warts and corns |
CN104189533A (zh) * | 2014-07-24 | 2014-12-10 | 于婷 | 一种治疗扁平疣的中药组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100349606C (zh) * | 2006-04-13 | 2007-11-21 | 马建国 | 一种治疗扁平疣的药酊及其制备方法 |
CN1895502A (zh) * | 2006-06-12 | 2007-01-17 | 刘爱玲 | 一种治疗扁平疣的合剂 |
-
2008
- 2008-04-03 CN CN2008100149576A patent/CN101254241B/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010086660A1 (en) * | 2009-01-30 | 2010-08-05 | Aria Healthcare Limited | Apparatus, method and composition for topical treatment of warts and corns |
CN104189533A (zh) * | 2014-07-24 | 2014-12-10 | 于婷 | 一种治疗扁平疣的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101254241B (zh) | 2012-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102139030B (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN102293947A (zh) | 一种治疗高血压的中药 | |
CN1240416C (zh) | 治疗高血压的药物及其制备方法 | |
CN104940784A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN101254241B (zh) | 一种用于治疗扁平疣的中药制剂 | |
CN103623280A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN114748603B (zh) | 一种防治新冠病毒肺炎变异或复阳的药物组合物和应用 | |
CN100386106C (zh) | 一种治疗痤疮的药物及其制备方法 | |
CN103432401B (zh) | 治疗肺癌的中药三花五子六白散 | |
CN106038995A (zh) | 一种用于治疗口周皮炎的中药冲剂及制备方法 | |
CN105396017A (zh) | 一种治疗脂肪肝的中药制剂及其制备方法 | |
CN101987159B (zh) | 一种治疗丹毒的药物及其制备方法 | |
CN103977182A (zh) | 一种治疗膝骨关节炎的中药贴膏及制备方法 | |
CN103721028B (zh) | 一种治疗心绞痛的药物及制备方法 | |
CN102370916A (zh) | 一种治疗急性肾小球肾炎的中药 | |
CN116350731B (zh) | 一种清热除湿通痹方及其制剂和应用 | |
CN103446410B (zh) | 一种治疗病毒性心肌炎的中药制剂 | |
CN102357160B (zh) | 一种治疗疟疾的中药 | |
CN102688401B (zh) | 治疗慢性肝炎茅根中药口服液及制备方法 | |
CN103055271B (zh) | 一种用于治疗慢性胃炎的药物及制备方法 | |
CN106728639A (zh) | 一种治疗老年痴呆的中药 | |
CN104784388A (zh) | 一种治疗淋巴结炎的中药外敷贴剂及制法 | |
CN103977195A (zh) | 一种治疗鼻咽癌的药物组合物 | |
CN118490788A (zh) | 一种利胆排石止痛的药物组合物、制剂及其制备方法和应用 | |
CN102671067A (zh) | 一种治疗急性肾小球肾炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120201 Termination date: 20130403 |